What's breaking now, across thousands of outlets.
OXFORD, England — The world's first therapy designed to fix a patient's unique genetic mutation cost $1.65 million to make, a key facilitator of the project revealed Wednesday at a rare disease conference in the UK. ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Health tech company CertifyOS is launching a new national model for provider credentialing, with several major payers already on board as participants.
Researchers at Trinity College Dublin, in collaboration with Breye Therapeutics, have found that an oral medication ("Danegaptide") can protect against vision-threatening damage in nonproliferative…
A joint team of researchers at Bar-Ilan University and the Weizmann Institute has used advanced computational design methods to enhance the ability of genetically engineered immune cells to recognize…
Former Ogun First Lady, Olufunso Amosun, has urged women not to see cancer as a death sentence, stressing that early detection and prompt treatment save li Read More…
Arc Raiders' executive producer, Aleksander Grøndal, spoke to us about how the team is handling the cheating problems within the game right now.
(MedPage Today) -- By the end of my first 24-hour shift (but more like 28 hours if we're being honest) in my third year of medical school, I'd seen two C-sections, and that's as much as I remember.
